Propofol-Remifentanil Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome

Electroconvulsive therapy can be effective in severe or treatment resistant neuroleptic malignant syndrome patients. Anesthesia and use of muscle relaxant agents for electroconvulsive therapy in such patients may encounter anesthesiologists with specific challenges. This case report describes succes...

Full description

Bibliographic Details
Published in:	Case Reports in Medicine
Main Authors:	Modabber Arasteh, Shoaleh Shami, Karim Nasseri
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Online Access:	http://dx.doi.org/10.1155/2012/585713

Similar Items

Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A case report
by: A. Osca Oliver, et al.
Published: (2023-03-01)

Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion
by: Quintí Foguet-Boreu, et al.
Published: (2018-01-01)

Comparison of the Effect of Propofol-Remifentanil versus Propofol-Ketamine on Hemodynamic Change and Seizure Duration in Electroconvulsive Therapy
by: Behzad Nazemroaya, et al.
Published: (2019-09-01)

Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report
by: Lauren Katzell, et al.
Published: (2023-03-01)

Neuroleptic malignant syndrome
by: Mariana Moscovich, et al.
Published: (2011-10-01)

Neuroleptic malignant syndrome
by: Bino Rajamani, et al.
Published: (2016-01-01)

Bitemporal ultra-brief pulse electroconvulsive therapy for the treatment of neuroleptic malignant syndrome in a first psychotic episode: a case report
by: Kathy Aleixo Marcolin, et al.

Neuroleptic Malignant Syndrome and Methylphenidate
by: J Gordon Millichap
Published: (1998-12-01)

Neuroleptic malignant syndrome after abrupt discontinuation of neuroleptic and anticholinergic drugs
by: Sameer Bhargava, et al.
Published: (2023-01-01)

Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics
by: Sandeep Grover, et al.
Published: (2012-01-01)

Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline
by: A. Bruce Janati, et al.
Published: (2012-01-01)

Comparison of remimazolam–remifentanil and propofol–remifentanil during laparoscopic cholecystectomy
by: Tae Young Lee, et al.
Published: (2023-07-01)

Comparison of the Propofol-Remifentanil and Desflurane-Remifentanil in Target-Controlled Infusion
by: Özlem Sezen, et al.
Published: (2020-06-01)

Neuroleptic malignant syndrome in clinical practices
by: Bugarinović Snežana M., et al.
Published: (2016-01-01)

Treatment of moderate neuroleptic malignant syndrome
by: Hossein Sanaei-Zadeh
Published: (2014-01-01)

Fluvoxamine-induced neuroleptic malignant syndrome
by: Adarsh Bellad, et al.
Published: (2017-01-01)

Olanzapine-induced neuroleptic malignant syndrome
by: Pradeep Kumar Saha, et al.
Published: (2017-01-01)

Olanzapine-Induced Neuroleptic Malignant Syndrome
by: Seyedhamze Hosseini, et al.
Published: (2017-05-01)

Clozapine Induced Neuroleptic Malignant Syndrome
by: Yong Suk Jo, et al.
Published: (2017-08-01)

Sedation for Colonoscopy: Comparison of Remifentanil and Alfentanil Combined with Propofol/Midazolam
by: Şule Arıcan, et al.
Published: (2019-11-01)

Comparison of remimazolam versus propofol in combination with remifentanil in hysteroscopic surgery
by: YAO Jinming, LI Yulan, XIN Yanming
Published: (2024-04-01)

The influence of norepinephrine and phenylephrine on cerebral perfusion and oxygenation during propofol–remifentanil and propofol–remifentanil–dexmedetomidine anaesthesia in piglets
by: Mai Louise Grandsgaard Mikkelsen, et al.
Published: (2018-02-01)

Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
by: Abebaw Fekadu, et al.
Published: (2005-01-01)

Neuroleptic malignant syndrome following clozapine withdrawal
by: Hamlin Tony, et al.
Published: (2024-01-01)

Neuroleptic malignant syndrome – a case report
by: Marcin Makuch, et al.
Published: (2019-07-01)

Síndrome neuroléptico maligno Neuroleptic malignant syndrome
by: Ricardo J. Toro, et al.
Published: (1989-02-01)

Neuroleptic Malignant Syndrome Associated with Colon-Cancer
by: Katsuhiko Tsukada, et al.
Published: (2007-01-01)

Total intravenous anesthesia: propofol/remifentanil vs midazolam/remifentanil in thoracic surgery
by: Miriam Falcón Guerra, et al.
Published: (2020-01-01)

Low dosage of aripiprazole induced neuroleptic malignant syndrome after interaction with other neuroleptic drugs
by: Albino Petrone, et al.
Published: (2013-09-01)

Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil
by: Prontera A, et al.
Published: (2017-03-01)

Neuroleptic Malign-like Syndrome Case Management in Intensive Care Unit
by: Kadir İDİN, et al.
Published: (2016-04-01)

Neuroleptic Malignant Syndrome - review of pathophysiology, clinical presentation, differentiation and management
by: Karolina Strus, et al.
Published: (2024-05-01)

The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
by: Forouzan Elyasi, et al.
Published: (2023-03-01)

Comparison of remifentanil and alfentanil in combination with propofol to facilitate laryngeal mask insertion.
by: AR AL Qattan, et al.
Published: (2003-01-01)

Pain reduction on injection of microemulsion propofol via combination of remifentanil and lidocaine
by: Yong Ku Han, et al.
Published: (2010-05-01)

Comparison of propofol-remifentanil and propofol-fentanyl anesthesia during ovariohysterectomy in dogs
by: KURUM B, et al.
Published: (2013-11-01)

The Comparison of the Effect of Ketamine-Sufentanil Combination and Propofol-Remifentanil Combination on the Quality of Sedation during Painful Procedures in Children with Hematological Malignancies
by: Hamidreza Shetabi, et al.
Published: (2018-07-01)

A Prospective, Randomized, Double-blinded Study on the Comparison of Propofol and Ketofol (Combination of Ketamine and Propofol) for Modified Electroconvulsive Therapy
by: Veena Mathur, et al.
Published: (2023-06-01)

Neuroleptic malignant syndrome associated with metoclopramide in a child
by: Ayhan Yaman, et al.
Published: (2014-10-01)

Anti-NMDAR Encephalitis developing neuroleptic malignant syndrome
by: Amandeep Singh Dhaliwal, et al.
Published: (2024-08-01)